1. Home
  2. NVST vs ICUI Comparison

NVST vs ICUI Comparison

Compare NVST & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NVST

Envista Holdings Corporation

SELL

Current Price

$23.28

Market Cap

3.8B

Sector

Health Care

ML Signal

SELL

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

SELL

Current Price

$167.11

Market Cap

4.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NVST
ICUI
Founded
2018
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.0B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
NVST
ICUI
Price
$23.28
$167.11
Analyst Decision
Buy
Buy
Analyst Count
15
8
Target Price
$28.69
★ $193.38
AVG Volume (30 Days)
★ 2.7M
224.5K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 104.31
100.62
EPS
0.56
★ 1.96
Revenue
★ $2,566,500,000.00
$2,231,262,000.00
Revenue This Year
$5.80
N/A
Revenue Next Year
$3.55
$4.44
P/E Ratio
★ $41.96
$85.38
Revenue Growth
★ N/A
N/A
52 Week Low
$18.77
$113.37
52 Week High
$30.42
$192.85

Technical Indicators

Market Signals
Indicator
NVST
ICUI
Relative Strength Index (RSI) 41.56 55.32
Support Level $22.69 $164.09
Resistance Level $23.94 $167.67
Average True Range (ATR) 0.58 3.94
MACD 0.13 1.09
Stochastic Oscillator 57.63 85.56

Price Performance

Historical Comparison
NVST
ICUI

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: